Search Results 271-280 of 2819 for ⚔[광고텔레:ADSFIX01] 바카라커뮤니티광고 대포장홍보 파워볼솔루션광고 개인장업체 카지노API 구글머니상홍보 노래방광고 토토디비광고 구글상단도배광고 상위노출대행⚔

  1. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    The purpose of this study is to evaluate the safety, effectiveness and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects 18 to ...

  2. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

  3. GS-4997 in Adults With Pulmonary Arterial Hypertension - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

  5. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...

  6. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of idasanutlin monotherapy in participants with hydroxyurea (HU)-resistant/intolerant ...

  7. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

    Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...

  8. A Study of Treatment with the Argus® II Retinal Prosthesis System - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Effect of Meditation on Emotional Buoyancy and Burnout in Physicians - Mayo Clinic

    This study aims to establish whether brief daily meditation will positively impact physicians' emotional buoyancy and overall well-being. Secondary outcomes ...

  10. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...